25 Sep The Difference Between NAD+, NMN, and NR, Explained
Supplement Notice: Dietary supplements, including NAD+ precursors such as NMN and NR, have not been evaluated by the FDA for safety or effectiveness before marketing and are not intended to diagnose, treat, cure, or prevent any disease or health condition. Supplements are not a substitute for regular medical care. Always consult a qualified healthcare provider before beginning any new supplement regimen. Patients with liver disease, cancer, are pregnant, nursing or may become pregnant or with long term use should be especially certain to discuss with medical provider before using.
Supplement marketing often treats NAD+, NMN, and NR as three names for the same thing. They are not. One is a coenzyme that cells use directly in metabolic reactions. The other two are precursor molecules that cells can convert into it. The distinction matters, because much of the confusion in this category sits in the gap between a precursor and the molecule it becomes. According to the NIH Office of Dietary Supplements, the niacin family — which includes nicotinamide, nicotinic acid, NMN, and NR — can all feed into NAD+ synthesis through existing cellular pathways, but each compound has a distinct structure, a distinct research record, and a distinct regulatory status.
[caption id="attachment_76240" align="aligncenter" width="500"] Photo by Nataliya Vaitkevich[/caption]